TickerLeague

Stock-Based Compensation for Tempus AI (TEM)

Stock-Based Compensation for Tempus AI (TEM): headline value $154.48M · YoY -76.6%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$154.48M

YoY change

-76.6%

5Y CAGR

+215.5%

Peak year (2024)

$534.14M

Latest annual

$124.75M

Stock-Based Compensation history chart for Tempus AI (TEM) from 2019 to 2025

Stock-Based Compensation history table for Tempus AI (TEM) from 2019 to 2025

Fiscal yearPeriod endedReportedStock-Based CompensationYoYYoY change
2025$124.75M-76.6%-$409.39M
2024$534.14M+$534.14M
2023$0$0
2022$0-100.0%-$559,000
2021$559,000+40.1%+$160,000
2020$399,000-24.6%-$130,000
2019$529,000

Stock-Based Compensation values are taken from Tempus AI's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Tempus AI (TEM) reported stock-based compensation of $124.75M – plunged 76.6% year-over-year.

Tempus AI stock-based compensation compound annual growth for the 2020–2025 (5 years) window is +215.5%, with the latest reading among the more recent periods of the dataset.

2024 marks the peak stock-based compensation at $534.14M, with the historical low of $0 recorded in 2022.

Within Healthcare, Tempus AI (TEM) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.

Tempus AI Stock-Based Compensation by Year

Tempus AI Stock-Based Compensation 2025: $124.75M

Tempus AI stock-based compensation in 2025 was $124.75M, plunged 76.6% below 2024.

Tempus AI Stock-Based Compensation 2024: $534.14M

Tempus AI stock-based compensation in 2024 was $534.14M.

Tempus AI Stock-Based Compensation 2023: $0

Tempus AI stock-based compensation in 2023 was $0.

Tempus AI Stock-Based Compensation 2022: $0

Tempus AI stock-based compensation in 2022 was $0, plunged 100.0% below 2021. This figure represents the lowest annual value in the available history.

Tempus AI Stock-Based Compensation 2021: $559,000

Tempus AI stock-based compensation in 2021 was $559,000.

See more financial history for Tempus AI (TEM).

Sector peers — Stock-Based Compensation

Companies in the same sector as Tempus AI, ranked by their latest stock-based compensation.

CompanyStock-Based CompensationSector
Johnson & Johnson (JNJ)$1.35BHealthcare
UnitedHealth Group (UNH)$971.00MHealthcare
AbbVie (ABBV)$955.00MHealthcare
Eli Lilly (LLY)$626.00MHealthcare
AstraZeneca (AZN)$0Healthcare
Merck & Co. (MRK)$0Healthcare
Novo Nordisk (NVO)$0Healthcare
Amgen (AMGN)$0Healthcare

Frequently asked questions

What is Tempus AI's stock-based compensation?

Latest reported stock-based compensation for Tempus AI (TEM) is $154.48M (period ending March 31, 2026).

How has Tempus AI stock-based compensation changed year-over-year?

Tempus AI (TEM) stock-based compensation changed -76.6% year-over-year on the latest annual filing.

What is the long-term growth rate of Tempus AI stock-based compensation?

Tempus AI (TEM) stock-based compensation compound annual growth rate is +215.5% over the most recent 5 years available.

When did Tempus AI stock-based compensation hit its highest annual value?

Tempus AI stock-based compensation reached its highest annual value of $534.14M in 2024.

What was Tempus AI stock-based compensation in 2024?

Tempus AI (TEM) stock-based compensation in 2024 was $534.14M.

What was Tempus AI stock-based compensation in 2025?

Tempus AI (TEM) stock-based compensation in 2025 was $124.75M.

TEM Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.